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 INFECTION
Pathological and microbiological impact 
of a gentamicin- loaded biocomposite 
following limited or extensive 
debridement in a porcine model 
of osteomyelitis
AN ANIMAL STUDY
Aims
CERAMENT|G is an absorbable gentamicin- loaded biocomposite used as an on- site vehicle of 
antimicrobials for the treatment of chronic osteomyelitis. The purpose of the present study 
was to investigate the sole effect of CERAMENT|G, i.e. without additional systemic antimicro-
bial therapy, in relation to a limited or extensive debridement of osteomyelitis lesions in a 
porcine model.
Methods
Osteomyelitis was induced in nine pigs by inoculation of 104 colony- forming units (CFUs) of 
Staphylococcus aureus into a drill hole in the right tibia. After one week, the pigs were allo-
cated into three groups. Group A (n = 3) received no treatment during the study period (19 
days). Groups B (n = 3) and C (n = 3) received limited or extensive debridement seven days 
postinoculation, respectively, followed by injection of CERAMENT|G into the bone voids. The 
pigs were euthanized ten (Group C) and 12 (Group B) days after the intervention.
Results
All animals presented confirmatory signs of bone infection post- mortem. The estimated 
amount of inflammation was substantially greater in Groups A and B compared to Group C. 
In both Groups B and C, peptide nucleic acid fluorescence in situ hybridization (PNA FISH) 
of CERAMENT|G and surrounding bone tissue revealed bacteria embedded in an opaque 
matrix, i.e. within biofilm. In addition, in Group C, the maximal measured post- mortem 
gentamicin concentrations in CERAMENT|G and surrounding bone tissue samples were 
16.6 µg/ml and 6.2 µg/ml, respectively.
Conclusion
The present study demonstrates that CERAMENT|G cannot be used as a standalone alterna-
tive to extensive debridement or be used without the addition of systemic antimicrobials.
Cite this article: Bone Joint Res 2020;9(7):394–401.
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Article focus
 This study aimed to describe the sole 
effect of CERAMENT|G in relation to a 
limited or extensive debridement of 
osteomyelitis lesions in a porcine model.
Key messages
 The estimated amount of infection and 
inflammation was substantially reduced 
for extensive debridement and applica-
tion of CERAMENT|G.
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 Despite type of debridement, biofilm formation was 
found around and inside CERAMENT|G ten to 12 days 
after revision surgery.
Strengths and limitations
 This is the first study to describe the penetration of 
CERAMENT|G into the surrounding bone tissue.
 The present study is a descriptive study and, there-
fore, a restricted number of animals were included.
Introduction
Bacterial contamination of implants and bone tissue is 
a serious complication in orthopaedic surgery and may 
result in development of bone infections.1 The most 
common causative bacteria are Staphylococcus aureus 
and Staphylococcus epidermidis, which are known for their 
ability to form biofilms.2 Bacteria living in biofilms show a 
high degree of tolerance towards the host immune system 
and antimicrobials.3 Therefore, treatment of bone infec-
tions comprises a combination of both surgical debride-
ment and long- term antimicrobial therapy, usually based 
on a multidisciplinary treatment protocol.4-6
Local antimicrobial carriers have evolved as a promising 
tool for treatment of orthopaedic infections both as bone 
void fillers and by delivering high antimicrobial concentra-
tions at the surgical site.7,8 The ideal antimicrobial- loaded 
bone void filler possesses properties such as biodegrad-
ability, biocompatibility, providing an osteoconductive 
and osteoinductive scaffold for healing, and elution of 
high levels of antimicrobials.6,9,10 CERAMENT|G (Bone-
Support AB, Lund, Sweden) is an injectable bone void 
filler composed of 60 wt% calcium sulphate and 40 wt% 
calcium hydroxyapatite (HA).9-11 Calcium sulphate (CS) 
is resorbed quickly and is thereby quickly replaced by 
newly formed osteoid and is effective at delivering high 
levels of antimicrobials.6,11 CERAMENT|G contains 175 mg 
gentamicin per 10 ml paste. The biodegradability of the 
product allows single- stage surgery and has previously 
been demonstrated to be highly efficient for treatment 
of chronic bone infections when combined with debride-
ment and systemic antimicrobials.9,11,12 In relation to a 
limited or extensive debridement of osteomyelitis lesions 
in a porcine model, the purpose of the present study was 
to elucidate the histopathological and microbiological 
impact of CERAMENT|G when used without simultane-
ously systemic antimicrobial treatment.
Methods
Experiment design. The experimental protocol was ap-
proved by The Danish Animal Experiments Inspectorate 
(license no. 2013/15-2934-00946). A well- established 
and characterized porcine model of implant- associated 
osteomyelitis was used.13 The present study is descrip-
tive and, therefore, a restricted number of experimental 
animals were included. To establish an infection, a small 
steel implant was inserted into the right tibial bone to-
gether with S. aureus bacteria. One week after surgery, 
the pigs were allocated into three groups (Table I). Group 
A (n = 3) received no treatment during the study peri-
od (19 days). One pig from this group (A1) was eutha-
nized after one week to confirm osteomyelitis at the time 
of revision surgery. Group B (n = 3) and Group C (n = 
3) animals received revision surgery seven days after in-
oculation with either limited or extensive debridement, 
respectively, followed by filling of the bone void with 
CERAMENT|G. None of the animals were treated systemi-
cally with antimicrobials.
Inoculum. A high- virulence gentamicin- sensitive S. au-
reus strain S54F9 (spa- type t1333), originally isolated 
from a chronic porcine lung abscess, was used to induce 
infection.14 This strain has been characterized by whole- 
genome sequencing,15 and has the ability to form biofilm 
both in vitro and in vivo.16 The final inoculum was 104 
colony- forming units (CFUs) in 10 µl.
CERAMENT|G. An injectable ceramic bone graft substitute 
(CERAMENT|G, PART NO: A0450-01, LOT: MLOT0599 
and MLOT0621), was supplied by BoneSupport. Each 
CERAMENT|G syringe included 10 ml paste and one sy-
ringe was used for each animal. Approximately 1 ml to 2 
ml of CERAMENT|G was administrated in Group B (limit-
ed debridement) and 4 ml to 6 ml in Group C (extensive 
debridement), respectively.
Surgical procedure and inoculation. A skin incision down to 
the periosteum was made 10 mm distal to and parallel with 
the growth plate of the right proximal tibia.13 An addition-
al incision was made through the periosteum. An implant 
cavity (IC) was created by drilling a Kirschner wire (K- wire; 
4 mm in diameter) 20 mm into the trabecular bone tissue 
at the site of the periosteal incision.13 Afterwards, the inocu-
lum was injected before insertion of a steel implant (K- wire 
of 2 mm × 10 mm). Finally, the periosteum, subcutaneous 
tissue, and skin were closed separately.13
Intervention (revision surgery). The infection was allowed 
to progress for one week before intervention (Groups B 
and C). Each animal received an intramuscular injection 
Table I. Experimental design.
Group Animals Inoculum Revision surgery 7 days after inoculation Time of euthanasia PI
A A1 S. aureus (104 CFUs) No revision 7 days
A2, A3 S. aureus (104 CFUs) No revision 19 days
B B1, B2, B3 S. aureus (104 CFUs) Limited debridement+ CERAMENT|G 19 days, 4 days (B3)
C C1, C2, C3 S. aureus (104 CFUs) Extensive debridement+ CERAMENT|G 17 days
CFU, colony forming unit; PI, postinoculation; S. aureus, Staphylococcus aureus.
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of 6.84  mg/kg gentamicin (Genta- Equine, 100  mg/ml; 
Dechra Veterinary Products SLU, Barcelona, Spain) prior 
to surgery in order to avoid development of surgery- 
related sepsis. Through the scar of the first surgery, the 
wound was opened. Soft- tissue abscesses were emptied 
and the IC was located. The implants were removed and 
placed in centrifuge tubes containing 2 ml sterile isotonic 
saline (0.9%). Implants and swabs from IC were sampled 
for microbiological evaluation. Limited debridement was 
performed in Group B animals. Limited debridement in-
volved curettage of membranes and necrotic bone tissue 
followed by rinsing of the bone void and subcutaneous 
tissue with isotonic sterile saline (0.9%). Extensive de-
bridement (Group C) included complete removal of sub-
cutaneous granulation tissue followed by curettage and 
excision of the necrotic bone and membranes until pint 
point bleedings from healthy bone tissue were present. 
Afterwards, the bone void and subcutaneous tissue were 
irrigated with isotonic sterile saline (0.9%). The definitions 
of debridement, i.e. limited or extensive, were defined 
in the protocol before revision surgery by the research 
team. Samples of the debrided tissue (bone and subcuta-
neous tissue) were saved for microbiological evaluation. 
After debridement (limited or extensive), the bone void 
was filled with CERAMENT|G. Finally, the periosteum, 
subcutaneous tissue, and skin were closed separately. 
The pigs were euthanized ten (Group C) or 12 (Group 
B) days after the intervention by an intravenous over-
dose of pentobarbital (Euthanimal, 365 mg/ml; ScanVet 
Animal Health A/S, Fredensborg, Denmark). All animals 
received daily oral analgesia with meloxicam (0.3 mg/kg 
BW, Metacam; Boehringer Ingelheim Vetmedica GmbH, 
Ingelheim am Rhein, Germany) and were monitored as 
described by Jensen et al13
CT scanning. After euthanasia, the right hind leg was 
scanned with a single slide CT scanner (Siemens 
Somatom Emotion; Siemens, Erlangen, Germany) to as-
sess the development of osteomyelitis. Tibia was scanned 
in the craniocaudal direction (slide thickness = 2 mm, kV 
= 130, and mAs = 55).13 A standard soft tissue algorithm 
(B80) was used. All scans were evaluated with Osirix Lite 
(OsiriX, Bernex, Switzerland).13
Pathology. The surgical wounds were macroscopically 
evaluated and opened down to the bone. The implants 
from animals in Group A were removed and placed in cen-
trifuge tubes containing 2 ml sterile isotonic saline (0.9%). 
In all animals, the right tibia was sagitally sectioned and 
macroscopically evaluated before being placed in 10% 
neutral formalin buffer for approximately two weeks. 
Formalin fixation of the tibial bones was followed by de-
calcification. The bone lesions were cut into representative 
pieces and embedded in paraffin. Tissue sections of 4 µm 
to 5 µm were stained with haematoxylin and eosin (H&E), 
Masson’s trichome, and immunohistochemistry (IHC) to-
wards S. aureus.14 Samples from Group C were also stained 
with a biofilm- specific stain based on a combination of IHC 
towards S. aureus and Alcian blue pH3.16 In all groups, the 
bone voids were localized and the pathological bone area 
(PBA) was measured.13 PBA was defined as the maximum 
perpendicular distance from the edge of the bone void (the 
IC in Group A) and until normal pattern of trabecular bone 
and marrow.13 The result was determined as the mean of 
two or more measurements in one histological section. 
Based on a method developed by Morawietz et al,17 the 
number of neutrophil granulocytes (NGs) and osteoclasts/
giant cells were counted within PBA. A maximum of ten 
NGs or osteoclasts/giant cells were counted in ten high 
power fields resulting in a maximum count of 100 per pig.17 
Table II. Results of the CT scans, macroscopic pathology, and gentamicin concentrations ten (Group C animals) and 12 (Group B animals) days after revision 
surgery in a porcine bone infection model. No revision surgery was performed for Group A. Revision surgery, Group B = limited debridement+ CERAMENT|G 
(CG). Revision surgery, Group C = extensive debridement+ CG.
Animal CT Macroscopic pathology Gentamicin concentration, µg/ml
Osteolysis Cortical 
sequester
Periosteal 
ossification
Sclerotic 
border
Sinus 
tract
Purulent 
osteomyelitis
CG - 
inside 
bone
CG - 
subcutis
Bone 
tissue 
distal to 
CG
Bone 
tissue 
proximal 
to CG
Bone 
tissue in 
level with 
CG
A1* N/A N/A N/A N/A Yes Yes N/A N/A N/A N/A N/A
A2† Yes No Yes Yes Yes Yes N/A N/A N/A N/A N/A
A3† Yes No Yes No Yes Yes N/A N/A N/A N/A N/A
B1 Yes Yes Yes Partly Yes Yes N/A N/A N/A N/A N/A
B2 Yes No Yes Partly Yes Yes N/A N/A N/A N/A N/A
B3‡ Yes Yes Yes Partly Yes Yes N/A N/A N/A N/A N/A
C1 Yes No Yes Yes Yes Yes 14.550 16.600 1.570 2.710 5.260
C2 Yes No Yes Yes Yes Yes 13.950 1.090 0.681 0.465 4.660
C3§ Yes No Yes Partly Yes Yes 1.420 6.240 0.704 0.653 0.533
*Pig euthanized seven days after inoculation.
†Pig euthanized 19 days after inoculation.
‡Pig euthanized four days after revision surgery.
§Pig with unrevised bone lesion, thereby representing limited debridement/Group B.
CG, CERAMENT|G; N/A, not available.
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To quantify the amount of collagen in PBA, a method de-
scribed by Street et al18 was used on the Masson’s trichome- 
stained sections. Areas rich in collagen were selected and 
using a percentage value, the amount of collagen in each 
field was scored (< 5%, 5% to 10%, 11% to 25%, 26% to 
50%, 51% to 75%, and 76% to 100%). These percentages 
were converted into a six- point scoring system, and a final 
mean score was calculated. Finally, slides were evaluated 
for bacterial/biofilm aggregates with IHC.13 To increase vali-
dation, all histological evaluations were carried out blinded.
Microbiology. Implants within sterile centrifuge tubes 
were placed in an ultrasonic bath and sonicated as pre-
viously described.19 After euthanasia, swabs were taken 
from the following areas: IC of Group A, the centre of 
CERAMENT|G, the bone surface towards CERAMENT|G, 
and subcutaneous tissue. In addition, bone samples and 
samples of CERAMENT|G were collected. All swabs and 
samples (including samples obtained at revision surgery) 
were smeared over Luria- Bertani agar plates and incubat-
ed at 37 °C for 24 hours. Furthermore, samples from the 
lungs were also obtained in order to analyze for systemic 
bacterial spreading. Any growth on the plates was spa- 
typed.20 Evaluations of swabs, bone samples, spa- typing, 
and sonication were performed blinded.
Peptide nucleic acid fluorescence in situ hybridiza-
tion. Bone lesions from pigs receiving CERAMENT|G 
(Groups B and C) were selected for peptic nucleic acid 
fluorescence in situ hybridization (PNA FISH) analysis as 
described by Bay et al21 In brief, sections were stained 
with TexasRed- labelled S. aureus- specific PNA probes 
(Advandx, Woburn, Massachusetts, USA) and counter- 
stained with a 4',6- diamidino-2- phenylindol (DAPI) DNA 
stain solution. Sections were imaged using a Zeiss LSM 
880 (Zeiss, Oberkochen, Germany) running ZEN 2.1. 
Images were obtained using a 63 × /1.4 oil objective and 
405 nm and 594 nm lasers with an emission band of 410 
nm to 465 nm and 600 nm to 660 nm. Images were pro-
cessed in Imaris 8.5 (Bitplane, Zürich, Switzerland).
Quantification of total homogenate gentamicin con-
centrations. From Group C pigs, small pieces of 
CERAMENT|G located in subcutaneous tissue and 
Fig. 1
CT scans (cranio- caudal direction) and macroscopic images obtained ten and 12 days after revision surgery in a porcine model of Staphylococcus aureus 
osteomyelitis. Pigs were treated with either limited debridement (A + B) or extensive debridement (C + D) followed by injection of CERAMENT|G into the bone 
voids. a) Osteomyelitis with osteolysis and irregular borders of the lesion. b) CERAMENT|G surrounded by pus and fibrosis. c) Regular sclerotic border of the 
bone void. d) CERAMENT|G surrounded by a rim of fibrosis.
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inside the bone were sampled together with adjacent 
bone tissue located distally, medially, and proximally 
to CERAMENT|G. All samples were kept at -80  °C un-
til analysis. During preparation, sample storage was 
kept in liquid nitrogen and all equipment kept cold. 
The samples were weighed, and sterile 0.9% sodium 
chloride (NaCl) 2 to 10× weight  volume was added. 
The material was homogenized using a Retsch titanium 
ball three times in succession for 30 seconds with a fre-
quency of 30 times per second. Then, the samples were 
spun for 1,000× g for 30  seconds, before being incu-
bated at 4 °C for 24 hours. Before the supernatant was 
transferred to a new vial for analysis, the samples were 
spun at 5,000× g for five minutes. The gentamicin con-
centrations in the supernatants were quantified using 
liquid chromatography tandem mass spectrometry.22 
The lower limit for quantitation was defined as the low-
est concentration with a total CV of 20% and was found 
to be 0.04 µg/ml.
Results
Apart from one pig (B3, limited debridement), all animals 
completed the study. Pig B3 was euthanized four days 
after revision surgery due to fever and apathy. Based on 
the necropsy, the pig was diagnosed with chronic, apos-
tematous disseminated pneumonia and pericarditis.
CT scanning. CT was not performed for pig A1. Signs 
of osteomyelitis like osteolysis and periosteal bone for-
mation were seen in all animals (Table II and Figures 1a 
and 1c). In general, the bone lesions in animals receiv-
ing limited debridement (Group B) were irregular, with 
cortical sequesters and with no clear sclerotic border 
(Figure 1a). In contrast, the pigs from Group C demon-
strated CERAMENT|G surrounded by a regular sclerotic 
border. However, in pig C3 the cavity with CERAMENT|G 
was communicating with a small osteolytic lesion with-
out a sclerotic border.
Bone pathology. All Group A pigs had a sinus tract drain-
ing the bone lesions. The bone lesion in pig A1 showed 
bone necrosis, pus, and fibrosis surrounding an enlarged 
and irregular IC. Comparable lesions were seen in pigs 
A2 and A3, although additional massive periosteal bone 
formation was observed around the cortical bone void.
The extraosseous findings in animals B1 and B2 were 
comparable to those in Group A pigs. In pig B3 (eutha-
nized four days after minor revision surgery), the subcu-
taneous tissue over the bone lesion was found to be 
necrotic. In all Group B pigs a white/grey substance, 
assumed to be CERAMENT|G, intermingled with yellow 
exudation appeared within the subcutaneous tissue adja-
cent to the filled bone void. Following sagittal sectioning 
of the tibial bones, Group B animals demonstrated CERA-
MENT|G surrounded by pus and fibrosis (Figure 1b). In 
cases of extensive debridement (animals C1 and C2) 
the extraosseous and osseous macroscopic findings 
were comparable to limited debridement, although 
with remarkably less periosteal bone formation, pus, 
and fibrosis around CERAMENT|G (Figure  1d). In pig 
C3, most of the CERAMENT|G was located outside the 
bone, i.e. in the subcutaneous tissue. Furthermore, pig 
C3 had a purulent bone lesion communicating with the 
CERAMENT|G- filled bone void.
Histopathologically, all bone lesions showed necrotic 
bone tissue and cell debris adjacent to the CERAMENT|G 
filled bone voids or IC, intermingled/surrounded by a cellular 
layer of NG, mononuclear cells, giant cells, and fibroblasts 
(granulation tissue and/or connective tissue). Furthermore, 
areas of newly formed osteoid and osteoclasts were occa-
sionally seen outside this cellular layer. All animals had a 
NG count of 100 and commonly, microabscesses (dense 
focal accumulation of neutrophils) were seen (Table  III). 
No differences in osteoclast/giant cell count were observed 
between the three groups. Trabecular sequesters were only 
observed in Groups A and B (Table  III). The distance of 
Table III. Results of histology ten (Group C animals) and 12 (Group B animals) days after revision surgery in a porcine bone infection model. No revision 
surgery was done for Group A. Treatment Group B = limited debridement+ CERAMENT|G (CG). Treatment Group C = extensive debridement+ CG.
Animal Histology PNA FISH/IHC positive bacteria within
Trabecular 
sequester
NG, n Micro- 
abscesses
Fibrosis 
score
Mean PBA, µm 
(SD)
CERAMENT|G 
(CG)
Adjacent bone 
to CG
Distant 
located to CG
A1* Yes 100 Yes 5 1385.84 (477.31) N/A N/A Yes
A2† No 100 Yes 5 2132.83 (2018.26) N/A N/A Yes
A3† Yes 100 Yes 4.4 1478.69 (1085.54) N/A N/A Yes
B1 Yes 100 Yes 4.3 1424.84 (433.32) Yes Yes Yes
B2 Yes 100 Yes 5 1851.9 (913.69) Yes Yes Yes
B3‡ No 100 Yes 4.8 1372.83 (580.3) Yes Yes Yes
C1 No 100 No 3.9 841.9 (348.97) Yes Yes No
C2 No 100 Yes 3.6 889.63 (427.64) Yes Yes No
C3§ No 100 Yes 5 2586.68 (1129.42) Yes Yes No
*Pig euthanized seven days after inoculation.
†Pig euthanized 19 days after inoculation.
‡Pig euthanized four days after revision surgery.
§Pig with unrevised bone lesion, thereby representing limited debridement/Group B.
IHC, immunohistochemistry; N/A, not applicable; NG, neutrophil granulocyte; PBA, pathological bone area; PNA FISH, peptide nucleic acid 
fluorescence in situ hybridization.
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bone pathology (PBA) surrounding the CERAMENT|G- filled 
bone voids was enlarged in Group B compared to Group 
C (Table III). In addition, a more manifest fibrotic response 
was also seen in Group B (Table III, Figures 2a and 2b). The 
localization of bacteria is reported in Table III and demon-
strated in Figures 3a to 3d. In Group C animals, positive 
Fig. 2
Histological findings within the pathological bone area (PBA) ten and 12 days after revision surgery in a porcine model of Staphylococcus aureus osteomyelitis. 
Pigs were treated with either a) extensive debridement or b) limited debridement followed by injection of CERAMENT|G into the bone voids. Fibrous tissue 
was located adjacent to the border of the bone void. A stronger fibrotic response was seen in the pig receiving limited debridement compared to the pig 
receiving extensive debridement. Masson’s trichome stain, magnification × 40. c, CERAMENT|G; f, fibrous tissue.
Fig. 3
Visualization of bacteria ten and 12 days after revision surgery in a porcine model of Staphylococcus aureus osteomyelitis. Pigs were treated with either limited 
(A + C) or extensive (B + D) debridement followed by injection of CERAMENT|G into the bone voids. a) Macroscopic picture showing removal of CERAMENT|G. 
Insert: Immunohistochemistry (IHC) towards S. aureus of the CERAMENT|G removed in Figure 3a; red bacteria are demonstrated here (× 200). b) Bone void 
border showing bacterial aggregates surrounded by pink matrix and neutrophil granulocytes inside CERAMENT|G; haematoxylin and eosin (HE) stain (× 100). 
c) Peptide nucleic acid fluorescence in situ hybridization (PNA FISH) of CERAMENT|G showing red aggregates of S. aureus (× 630). d) Biofilm forming S. aureus 
in CERAMENT|G; red bacteria surrounded by a blue matrix is seen here, image produced with IHC combined with Alcian blue pH3 (× 400). c, CERAMENT|G.
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biofilm double staining of matrix and bacterial cells was 
present (Figure 3d).
Microbiology. All located implants were positive for bac-
terial attachment and the mean bacterial load was 105 
CFUs/ml. All swabs and bone samples taken at the time 
of revision surgery and euthanasia were positive for S. 
aureus. Furthermore, all CERAMENT|G samples and bone 
samples surrounding CERAMENT|G were positive for S. 
aureus in both Groups B and C. In addition, S. aureus was 
observed in the lung tissue of one pig (Group A1). All 
S. aureus positive samples were confirmed to contain S. 
aureus spa type t1333, i.e. identical to the spa type used 
for inoculation.
PNA FISH. All bone lesions from Groups B and C were 
positive for S. aureus by PNA FISH (Table III). The bacteria 
were present as single cells as well as small aggregates of 
cocci embedded in an opaque matrix, indicating biofilm 
formation.
Gentamicin concentrations. The gentamicin concentra-
tions are reported in Table II. The maximal measured gen-
tamicin concentrations of CERAMENT|G samples located 
in subcutaneous tissue and bone voids were 16.6 µg/ml 
and 14.5 µg/ml, respectively. However, in pig C3, which 
had a small purulent lesion communicating with the 
bone void of revision surgery, all the CERAMENT|G gen-
tamicin concentrations were below 6.2 µg/ml (Table II).
Discussion
Local administration of CERAMENT|G, without additional 
systemic antimicrobial therapy, could not eradicate 
infection following either limited or extensive debride-
ment in a porcine osteomyelitis model inoculated with 
a high- virulence gentamicin- susceptible S. aureus strain. 
In both groups of debridement, the inoculated strain 
could be isolated from CERAMENT|G and surrounding 
bone tissue. Moreover, biofilm formation was evident 
due to bacteria in clusters surrounded by extracellular 
matrix and persistent infection despite exposure to an 
antimicrobial agent to which the causative organism 
was sensitive.23 However, the amount of inflammation, 
or expansion of lesions into the bone tissue surrounding 
the CERAMENT|G- filled bone voids (created during 
revision surgery), was highly different between limited 
and extensive debridement. The bone lesions in Group 
B (limited debridement) were progressing, resulting 
in substantial bone loss. Signs of expansion of lesions 
in Group B included irregular contour of bone lesions, 
no sclerotic border, distant located bacteria, and high 
PBA values and collagen scores. In contrast, pathology 
and CT scan indicated that the bone voids created with 
successful extensive debridement and filled with CERA-
MENT|G (pigs C1 and C2) were contained/unchanged 
in the second postoperative period. Thus, the combina-
tion of extensive debridement and CERAMENT|G holds 
the remnant infection in an initial non- progressing state. 
However, in one Group C pig the bone void formed 
during revision surgery was connected to an unrevised 
bone lesion, thereby representing a limited debridement 
(artificial).
In a recent preclinical study, the effect of CERAMENT|G 
was evaluated in a murine fracture model of implant- 
related S. aureus osteitis.10 Lavage and debridement was 
performed before implantation of the product, and a final 
lavage was obtained again on the day of euthanization.10 
Although based on lavage, and not bone tissue samples, 
all samples were positive for bacteria. Therefore, it was 
concluded that the application of the antimicrobial- 
impregnated material in an acute implant- associated 
infection did not cure the lesion.10 This corresponds to the 
findings of the present preclinical study. In accordance 
with our observations, biofilm formation in antimicrobial- 
loaded carriers has also been described in the clinic. In a 
paper by Stoodley et al,24 viable biofilm growing bacteria 
were demonstrated in tobramycin- impregnated bone 
cement from a patient with total joint arthroplasty. In the 
present study, it can be speculated that the bone tissue 
concentration of gentamicin obtained from CERAMENT|G 
was too low to eradicate remnants of mature biofilms left 
behind after debridement, thereby allowing the carrier 
product to be colonized. This is supported by the low 
gentamicin concentrations measured in the bone tissue 
surrounding CERAMENT|G. Another study based on a 
noninfectious rabbit model also demonstrated low genta-
micin tissue concentrations released from gentamicin- 
loaded calcium sulphate.25 In both the rabbit model25 and 
the present porcine model, the total gentamicin concen-
trations were estimated based on homogenized bone 
samples. However, it is important to appreciate that only 
the unbound gentamicin concentrations from the inter-
stitial fluid are considered to be microbiologically active. 
As with most local antimicrobials, the true in vivo phar-
macokinetic behaviour of CERAMENT|G remains dubious. 
It is unknown whether gentamicin is actually able to 
penetrate into the peri- carrier- tissue in anti- biofilm effi-
cient concentrations. The gentamicin concentration 
released from CERAMENT|G is highly dependent on local 
factors such as bleeding, suppuration, increased vascular 
permeability, increased blood flow, and exudation of 
plasma proteins.19 All these factors may contribute to an 
uncontrolled dilution of the gentamicin concentration, 
resulting in a fast gentamicin removal from the local site 
as seen in pig C3.
Several clinical studies support the use of antimicrobial- 
impregnated CS/HA as an on- site vehicle in the treatment 
of chronic osteomyelitis,8,9,11,12,26 but essentially combined 
with systemic antimicrobials and extensive debride-
ment.9,12 The present study emphasizes that the bone 
tissue which envelopes the antimicrobial carriers can act 
as a reservoir for biofilms even after extensive debride-
ment. In conclusion, CERAMENT|G cannot be used as an 
alternative to extensive debridement, i.e. CERAMENT|G 
should not be used in an effort to save bone tissue. 
Extensive debridement and application of CERAMENT|G 
reduced progression of infection and inflammation 
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and, therefore, CERAMENT|G currently may be used as 
a complementary to systemic antimicrobial therapy and 
the immune system in eradication of bone infections.12
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